Crossmark

Barriers and attitudes reported by Canadian emergency physicians regarding the initiation of buprenorphine/naloxone in the emergency department for patients with opioid use disorder

Crossref DOI link: https://doi.org/10.1007/s43678-021-00191-y

Published Online: 2021-09-25

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Savage, Tyson

Ross, Marshall
Funding

Funding for this research was provided by:

University of Calgary (Grant Innes Resident Research Award)
License Information

Text and Data Mining valid from 2021-09-25

Version of Record valid from 2021-09-25
More Information

Article History

Received: 1 May 2021

Accepted: 5 August 2021

First Online: 25 September 2021

Change Date: 14 October 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s43678-021-00219-3

Updates are available Correction dated 2021-10-14

Click to view Correction: https://doi.org/10.1007/s43678-021-00219-3